Sector index · Health and life sciences · 2026
Gene and cell therapy, genome editing, synthetic biology, antibodies and biomanufacturing.
Ranked universities have at least 20 verified industry works in this sector (2021-2025). Score: volume 30%, reach 25% (company groups with 2+ joint works), repeat partnerships 25% (3+ works over 2+ years) and network influence 20%, each as a percentile within this sector's pool of 220.
| # | University | Country | Score | Works | Partners | Leading partners |
|---|---|---|---|---|---|---|
| 1 | Harvard University | United States | 99.5 | 307 | 55 | Bristol-Myers Squibb, Roche, Johnson & Johnson |
| 2 | University of Pennsylvania | United States | 99.3 | 268 | 52 | Novartis, Johnson & Johnson, Legend Biotech |
| 3 | Stanford University | United States | 99.0 | 238 | 54 | Gilead Sciences, Bristol-Myers Squibb, AstraZeneca |
| 4 | Seoul National University | South Korea | 97.7 | 154 | 33 | Samsung, Regeneron, ToolGen |
| 5 | University College London | United Kingdom | 97.5 | 182 | 38 | Autolus, Roche, AstraZeneca |
| 6 | University of California, San Francisco | United States | 97.3 | 191 | 31 | Johnson & Johnson, Novartis, Legend Biotech |
| 7 | University of Oxford | United Kingdom | 96.3 | 126 | 32 | Roche, GlaxoSmithKline, Evox Therapeutics |
| 8 | Université Paris Cité | France | 95.8 | 130 | 29 | Novartis, Genmab, AbbVie |
| 9 | Washington University in St. Louis | United States | 95.2 | 146 | 29 | Roche, Gilead Sciences, Adaptimmune |
| 10 | Heidelberg University | Germany | 95.1 | 129 | 29 | Roche, Bristol-Myers Squibb, Miltenyi Biotec |
| 11 | University of Washington | United States | 94.2 | 123 | 26 | Pfizer, Gilead Sciences, Bristol-Myers Squibb |
| 12 | Johns Hopkins University | United States | 93.4 | 114 | 25 | AstraZeneca, Bristol-Myers Squibb, Merck & Co. (MSD) |
| 13 | Medical College of Wisconsin | United States | 92.8 | 132 | 21 | Johnson & Johnson, Novartis, Bristol-Myers Squibb |
| 14 | Peking University | China | 92.7 | 109 | 22 | CARsgen Therapeutics, BGI Group, Beijing Chemical Industry Research InstituteSTATE-OWNED |
| 15 | Cornell University | United States | 91.8 | 124 | 28 | Regeneron, Bristol-Myers Squibb, Pfizer |
| 16 | Kyoto University | Japan | 91.8 | 104 | 19 | Takeda, Novartis, Gunze |
| 17 | University of California San Diego | United States | 91.2 | 110 | 28 | AstraZeneca, Altos Labs, Pfizer |
| 18 | University of Michigan | United States | 90.9 | 104 | 24 | Novartis, AbbVie, Genmab |
| 19 | King's College London | United Kingdom | 89.8 | 96 | 21 | Leucid Bio, AstraZeneca, Novartis |
| 20 | Ludwig-Maximilians-Universität München | Germany | 89.7 | 116 | 18 | Roche, Novartis, Miltenyi Biotec |
| 21 | The Ohio State University | United States | 89.5 | 98 | 23 | Novartis, AstraZeneca, Emmes |
| 22 | Emory University | United States | 88.9 | 108 | 19 | Novartis, Bristol-Myers Squibb, Johnson & Johnson |
| 23 | University of Minnesota | United States | 88.6 | 100 | 18 | Emmes, Bristol-Myers Squibb, Novartis |
| 24 | Karolinska Institutet | Sweden | 88.3 | 115 | 17 | AstraZeneca, Evox Therapeutics, Bristol-Myers Squibb |
| 25 | Massachusetts Institute of Technology | United States | 87.2 | 90 | 22 | Roche, Sanofi, Microsoft |
| 26 | Icahn School of Medicine at Mount Sinai | United States | 87.1 | 95 | 20 | Johnson & Johnson, AbbVie, Bristol-Myers Squibb |
| 27 | University of Cambridge | United Kingdom | 87.1 | 106 | 16 | AstraZeneca, BGI Group, Novo Nordisk |
| 28 | Chinese Academy of Medical Sciences & Peking Union Medical College | China | 86.8 | 112 | 17 | BGI Group, Nanjing IASO Biotechnology Co., Juventas Cell Therapy Ltd. |
| 29 | University of Chinese Academy of Sciences | China | 86.2 | 194 | 15 | BGI Group, Tencent |
| 30 | University of Copenhagen | Denmark | 85.5 | 102 | 15 | BGI Group, Novo Nordisk, Roche |
| 31 | Medical University of Vienna | Austria | 85.5 | 76 | 19 | Novartis, Boehringer Ingelheim, Celltrion |
| 32 | University of Pittsburgh | United States | 85.0 | 86 | 18 | Bristol-Myers Squibb, BioLegend, Iovance Biotherapeutics |
| 33 | Duke University | United States | 83.9 | 82 | 18 | Novartis, Moderna Therapeutics, AstraZeneca |
| 34 | University of Toronto | Canada | 81.9 | 78 | 15 | Celltrion, AstraZeneca, Novartis |
| 35 | Shanghai Jiao Tong University | China | 81.8 | 76 | 14 | BGI Group, SinopecSTATE-OWNED |
| 36 | The University of Osaka | Japan | 81.3 | 77 | 17 | Kyowa Kirin, Novartis, Teijin |
| 37 | Utrecht University | Netherlands | 80.3 | 78 | 12 | Philips, Roche, Evox Therapeutics |
| 38 | Sorbonne Université | France | 80.1 | 78 | 17 | Sanofi, Jazz Pharmaceuticals, Biogen |
| 39 | The University of Melbourne | Australia | 79.8 | 92 | 15 | Roche, Novartis, Johnson & Johnson |
| 40 | Université Claude Bernard Lyon 1 | France | 79.5 | 74 | 14 | Novartis, Roche, Sanofi |
| 41 | University of California, Los Angeles | United States | 78.5 | 85 | 15 | Gilead Sciences, Amgen, AbbVie |
| 42 | University of Zurich | Switzerland | 78.4 | 71 | 12 | Roche, Philochem, Philogen |
| 43 | University of Chicago | United States | 78.3 | 98 | 15 | Novartis, Johnson & Johnson, Legend Biotech |
| 44 | Zhejiang University | China | 77.1 | 90 | 10 | BGI Group, Shanghai YaKe Biotechnology, GeneX (Zhejiang) Precision Medicine |
| 45 | Universität Hamburg | Germany | 76.8 | 64 | 16 | Johnson & Johnson, Legend Biotech, Miltenyi Biotec |
| 46 | Yale University | United States | 76.3 | 72 | 11 | Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim |
| 47 | The University of Tokyo | Japan | 76.1 | 74 | 17 | Tosoh, Toagosei, Ajinomoto |
| 48 | Oregon Health & Science University | United States | 76.0 | 76 | 11 | Novartis, Analysis Group, CSL |
| 49 | University of North Carolina at Chapel Hill | United States | 75.7 | 64 | 15 | CSL, Amgen, Pfizer |
| 50 | Sun Yat-sen University | China | 75.4 | 91 | 16 | BGI Group, Innovent Biologics, Antengene Corporation Limited |
| 51 | The University of Sydney | Australia | 74.7 | 62 | 13 | Novartis, AbbVie, Bristol-Myers Squibb |
| 52 | Northwestern University | United States | 74.1 | 69 | 12 | Bristol-Myers Squibb, LanzaTech, Regeneron |
| 53 | ETH Zurich | Switzerland | 73.1 | 71 | 11 | Philochem, Roche, Philogen |
| 54 | Fudan University | China | 72.4 | 81 | 9 | BGI Group, Tencent |
| 55 | University of Colorado Denver | United States | 71.8 | 69 | 13 | Bristol-Myers Squibb, Novartis, Iovance Biotherapeutics |
| 56 | University of Miami | United States | 71.5 | 67 | 11 | Gilead Sciences, Merck & Co. (MSD), Bristol-Myers Squibb |
| 57 | Ghent University | Belgium | 71.2 | 45 | 16 | Boehringer Ingelheim, Roche, Johnson & Johnson |
| 58 | Uppsala University | Sweden | 71.0 | 58 | 9 | Affibody, BioArctic, AstraZeneca |
| 59 | Goethe University Frankfurt | Germany | 70.8 | 62 | 13 | Miltenyi Biotec, Novartis, CSL |
| 60 | University of British Columbia | Canada | 70.6 | 56 | 11 | Roche, AbbVie, Bristol-Myers Squibb |
| 61 | KU Leuven | Belgium | 70.2 | 54 | 16 | Roche, Regeneron, Johnson & Johnson |
| 62 | Sungkyunkwan University | South Korea | 70.2 | 60 | 10 | ENCell Co., Samsung, Kyowa Kirin |
| 63 | Huazhong University of Science and Technology | China | 70.0 | 68 | 10 | Nanjing IASO Biotechnology Co., BGI Group, Innovent Biologics |
| 64 | Medizinische Hochschule Hannover | Germany | 69.5 | 50 | 18 | Miltenyi Biotec, Boehringer Ingelheim, BioNTech |
| 65 | University of Tübingen | Germany | 68.6 | 54 | 13 | Miltenyi Biotec, Johnson & Johnson, Boehringer Ingelheim |
| 66 | Yonsei University | South Korea | 67.8 | 54 | 17 | LG, Seagen, LG AI Research |
| 67 | Rutgers, The State University of New Jersey | United States | 67.6 | 56 | 9 | AstraZeneca, Roche, Merck & Co. (MSD) |
| 68 | Imperial College London | United Kingdom | 67.5 | 74 | 8 | AstraZeneca, Boehringer Ingelheim, Novartis |
| 69 | University of Utah | United States | 67.0 | 60 | 9 | Novartis, Johnson & Johnson, Bristol-Myers Squibb |
| 70 | Technical University of Munich | Germany | 66.9 | 55 | 10 | Roche, Boehringer Ingelheim, Bristol-Myers Squibb |
| 71 | University of Amsterdam | Netherlands | 66.7 | 63 | 13 | Novartis, Gilead Sciences, Galapagos |
| 72 | Vrije Universiteit Amsterdam | Netherlands | 65.5 | 60 | 10 | Johnson & Johnson, Legend Biotech, Lava Therapeutics |
| 73 | Columbia University | United States | 65.5 | 57 | 12 | Pfizer, Genomic Prediction, NeuroDex |
| 74 | Technical University of Denmark | Denmark | 65.4 | 44 | 9 | AstraZeneca, Roche, Novo Nordisk |
| 75 | Universidad de Navarra | Spain | 65.0 | 38 | 12 | Johnson & Johnson, Vivet Therapeutics, Roche |
| 76 | University of Maryland, Baltimore | United States | 64.7 | 60 | 11 | Gilead Sciences, Bristol-Myers Squibb, Merck & Co. (MSD) |
| 77 | Johannes Gutenberg University Mainz | Germany | 64.5 | 54 | 8 | BioNTech, Boehringer Ingelheim, Gilead Sciences |
| 78 | Vanderbilt University | United States | 64.5 | 51 | 10 | Alnylam Pharmaceuticals, Gilead Sciences, AstraZeneca |
| 79 | University of California, Berkeley | United States | 62.6 | 46 | 14 | Roche, Google, Amgen |
| 80 | Lund University | Sweden | 61.1 | 46 | 9 | AstraZeneca, Alligator Bioscience, Roche |
| 81 | Baylor College of Medicine | United States | 60.4 | 50 | 10 | Bristol-Myers Squibb, AstraZeneca, Novartis |
| 82 | Hokkaido University | Japan | 60.4 | 44 | 13 | Novartis, Nitto, Kaneka |
| 83 | Indiana University | United States | 59.5 | 58 | 17 | Ossium Health, Pfizer, Merck & Co. (MSD) |
| 84 | Université Paris-Saclay | France | 59.1 | 52 | 7 | Sanofi, Novartis, Roche |
| 85 | University of Alabama at Birmingham | United States | 58.5 | 54 | 9 | Johnson & Johnson, Bristol-Myers Squibb, Emmes |
| 86 | University of Bologna | Italy | 58.5 | 38 | 14 | Novartis, AbbVie, AstraZeneca |
| 87 | University of Florida | United States | 58.0 | 48 | 9 | AstraZeneca, Roche, Pfizer |
| 88 | University of Ulsan | South Korea | 57.5 | 46 | 10 | AstraZeneca, Celltrion, Sanofi |
| 89 | University of Massachusetts Chan Medical School | United States | 57.2 | 42 | 9 | Pfizer, Celltrion, Roche |
| 90 | University of Basel | Switzerland | 57.1 | 62 | 7 | Roche, Novartis, Edelweiss Connect |
| 91 | University of Freiburg | Germany | 56.9 | 50 | 9 | Miltenyi Biotec, Novartis, AstraZeneca |
| 92 | Universitat de Barcelona | Spain | 56.5 | 47 | 8 | Roche, Genmab, AbbVie |
| 93 | Universitat Autònoma de Barcelona | Spain | 56.4 | 48 | 8 | Roche, Novartis, Thermo Fisher Scientific |
| 94 | Monash University | Australia | 56.4 | 44 | 11 | AstraZeneca, Roche, Tencent |
| 95 | University of Oslo | Norway | 53.7 | 38 | 9 | Roche, Boehringer Ingelheim, AstraZeneca |
| 96 | Tsinghua University | China | 52.8 | 54 | 5 | BGI Group, Tencent, China National Petroleum Corporation (CNPC)STATE-OWNED |
| 97 | University of Southampton | United Kingdom | 52.4 | 36 | 8 | BioInvent, UCB Pharma, Roche |
| 98 | Guangzhou Medical University | China | 51.6 | 42 | 8 | BGI Group, Guangzhou Bio-Gene Technology, Guangzhou Electronic Technology |
| 99 | Vita-Salute San Raffaele University | Italy | 51.4 | 40 | 8 | Takeda, Novartis, Merck KGaA |
| 100 | University of Manchester | United Kingdom | 51.0 | 44 | 9 | AstraZeneca, Roche, Bristol-Myers Squibb |
| 101 | National University of Singapore | Singapore | 50.8 | 50 | 7 | BGI Group, Zhejiang Biocare Biotechnology, HUIDAGENE Therapeutics |
| 102 | University of Milan | Italy | 49.8 | 45 | 7 | Roche, Novartis, Chiome Bioscience Inc. |
| 103 | Nantes Université | France | 49.4 | 39 | 9 | Roche, Johnson & Johnson, Sanofi |
| 104 | Ulsan College | South Korea | 49.2 | 38 | 9 | AstraZeneca, Sanofi, Roche |
| 105 | Nagoya University | Japan | 48.5 | 34 | 8 | Novartis, Takara BIO Inc., Takara |
| 106 | Université de Lille | France | 48.0 | 42 | 7 | Roche, Bristol-Myers Squibb, Jazz Pharmaceuticals |
| 107 | KTH Royal Institute of Technology | Sweden | 47.9 | 34 | 12 | Affibody, BGI Group, AstraZeneca |
| 108 | Aix-Marseille Université | France | 47.7 | 43 | 7 | Jazz Pharmaceuticals, Novartis, Boehringer Ingelheim |
| 109 | University of Helsinki | Finland | 47.5 | 38 | 6 | Orion Corporation, Merck & Co. (MSD), Bayer |
| 110 | University of Edinburgh | United Kingdom | 47.5 | 42 | 9 | AstraZeneca, Boehringer Ingelheim, Roche |
| 111 | Catholic University of Korea | South Korea | 47.4 | 32 | 8 | Regeneron, AstraZeneca, Celltrion |
| 112 | Southern Medical University | China | 47.4 | 44 | 5 | BGI Group, Guangzhou Electronic Technology, Guangzhou Bio-Gene Technology |
| 113 | Capital Medical University | China | 47.2 | 44 | 7 | Altos Labs, Echo Biotech, CARsgen Therapeutics |
| 114 | University of Sheffield | United Kingdom | 47.0 | 32 | 8 | Hexal, AstraZeneca, Sanofi |
| 115 | Soochow University | China | 45.7 | 37 | 6 | PersonGen, Innovent Biologics, Takeda |
| 116 | Weill Cornell Medicine | United States | 45.3 | 46 | 11 | AbbVie, Eureka Therapeutics, Regeneron |
| 117 | Aarhus University | Denmark | 45.1 | 36 | 6 | BGI Group, AstraZeneca, Novo Nordisk |
| 118 | Tel Aviv University | Israel | 44.4 | 40 | 5 | Johnson & Johnson, Legend Biotech, Novartis |
| 119 | Saarland University | Germany | 44.4 | 22 | 18 | Roche, Novo Nordisk, Bioneer |
| 120 | University of Groningen | Netherlands | 44.2 | 36 | 8 | AbbVie, AstraZeneca, Bayer |
| 121 | Nankai University | China | 43.6 | 30 | 8 | BGI Group, Tianjin Institute of Pharmaceutical Research |
| 122 | Sichuan University | China | 42.9 | 44 | 7 | Tasly Holding Group, Innovent Biologics, BioTalentum |
| 123 | RWTH Aachen University | Germany | 42.7 | 33 | 7 | Life & Brain, Miltenyi Biotec, Boehringer Ingelheim |
| 124 | Zhengzhou University | China | 41.1 | 42 | 4 | BGI Group, Shenzhen Pregene Biopharma Co., Jiangsu Hengrui Medicine |
| 125 | University at Buffalo, State University of New York | United States | 40.9 | 28 | 7 | AstraZeneca, Roche, Sanofi |
| 126 | Tianjin Medical University | China | 40.0 | 28 | 5 | Beijing Biosis Healing Biological Technology, SinopecSTATE-OWNED |
| 127 | University of California, Davis | United States | 39.6 | 42 | 7 | Gilead Sciences, Roche, Abcam |
| 128 | Technische Universität Darmstadt | Germany | 39.5 | 42 | 2 | Merck KGaA, Ferring Pharmaceuticals, Abcalis |
| 129 | University of Iowa | United States | 39.3 | 37 | 10 | Pfizer, Feldan, Abcam |
| 130 | University of Naples Federico II | Italy | 39.2 | 32 | 4 | Nouscom, Chiome Bioscience Inc., AstraZeneca |
| 131 | Charles University | Czechia | 39.1 | 31 | 6 | Roche, Genmab, AbbVie |
| 131 | Semmelweis University | Hungary | 39.1 | 38 | 6 | MorphoSys, Pharmahungary Group, Syreon Research Institute |
| 133 | University of California, Irvine | United States | 39.0 | 40 | 7 | Regeneron, Gilead Sciences, Amgen |
| 134 | Nanjing Medical University | China | 38.6 | 36 | 6 | CanSino, Tymora Analytical Operations, Legend Biotech |
| 135 | The University of Queensland | Australia | 38.6 | 30 | 6 | Akoya Biosciences, CSL, AstraZeneca |
| 135 | Northeastern University | United States | 38.6 | 31 | 5 | Moderna Therapeutics, Sanofi, Pfizer |
| 137 | University of Bern | Switzerland | 38.4 | 32 | 5 | Roche, CSL, Novartis |
| 138 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Germany | 38.1 | 30 | 6 | Kyverna Therapeutics, Bristol-Myers Squibb, Lucideon |
| 139 | Kyushu University | Japan | 38.0 | 43 | 4 | Novartis, Daiichi Sankyo, Servier |
| 140 | Wayne State University | United States | 37.9 | 30 | 8 | Legend Biotech, Johnson & Johnson, Poseida Therapeutics |
| 141 | McGill University | Canada | 37.7 | 38 | 7 | Roche, Eli Lilly, Alnylam Pharmaceuticals |
| 142 | University of Cologne | Germany | 36.9 | 34 | 7 | Novartis, Miltenyi Biotec, Johnson & Johnson |
| 143 | Indiana University - Purdue University Indianapolis | United States | 36.2 | 40 | 9 | Ossium Health, Bristol-Myers Squibb, Merck & Co. (MSD) |
| 144 | University of Duisburg-Essen | Germany | 35.2 | 33 | 7 | Evox Therapeutics, Novartis, Evercyte |
| 145 | University of Southern California | United States | 35.2 | 38 | 6 | Novartis, Roche, Gilead Sciences |
| 146 | South China University of Technology | China | 34.8 | 42 | 3 | BGI Group, Fosun Pharma, RayBiotech |
| 147 | Georgetown University | United States | 34.2 | 29 | 5 | Johnson & Johnson, Gilead Sciences, Bayer |
| 148 | Jilin University | China | 33.1 | 33 | 4 | BGI Group, Jiangsu Hengrui Medicine, Innovent Biologics |
| 149 | University of Birmingham | United Kingdom | 33.1 | 32 | 6 | Waters, Roche, QVQ Holding |
| 150 | Leiden University | Netherlands | 32.9 | 25 | 7 | Genmab, Merck KGaA, BioNTech |
| 151 | Boston University | United States | 32.3 | 34 | 7 | Bristol-Myers Squibb, Roche, Emulate |
| 152 | UNSW Sydney | Australia | 32.2 | 31 | 5 | Roche, Novartis, AstraZeneca |
| 153 | Université Paris Sciences et Lettres | France | 31.7 | 31 | 5 | Sanofi, Evox Therapeutics, Google |
| 154 | University of Rochester | United States | 31.1 | 37 | 4 | Gilead Sciences, Bristol-Myers Squibb, Moderna Therapeutics |
| 155 | University of Turin | Italy | 31.0 | 30 | 4 | Merck KGaA, Johnson & Johnson, Legend Biotech |
| 156 | Korea University | South Korea | 30.9 | 30 | 5 | Samsung, S. Biomedics, Geninus |
| 157 | Fujian Medical University | China | 30.9 | 27 | 8 | BGI Group, HUIDAGENE Therapeutics, HUIEDIT Therapeutics |
| 158 | Heinrich Heine University Düsseldorf | Germany | 30.5 | 28 | 7 | Miltenyi Biotec, TG Therapeutics, Horizon Therapeutics |
| 159 | Purdue University West Lafayette | United States | 30.1 | 27 | 5 | Tymora Analytical Operations, Eli Lilly, Merck & Co. (MSD) |
| 160 | Radboud University Nijmegen | Netherlands | 29.8 | 26 | 11 | Philips, SyMO-Chem, Biotrip |
| 161 | University of Tsukuba | Japan | 29.4 | 28 | 5 | Eisai, Kaneka, Astellas Pharma |
| 162 | Tongji University | China | 29.0 | 30 | 4 | Roche, Johnson & Johnson, Shanghai AbelZeta Ltd. |
| 163 | Wageningen University & Research | Netherlands | 28.5 | 28 | 4 | LifeGlimmer, Corbion, FrieslandCampina |
| 164 | University of Nottingham | United Kingdom | 27.9 | 28 | 4 | TAmiRNA, AstraZeneca, Pharmahungary Group |
| 165 | Keio University | Japan | 27.6 | 28 | 5 | Novartis, Nippon Kayaku, Takara |
| 166 | New York University | United States | 27.2 | 36 | 4 | BioLegend, AstraZeneca, Regeneron |
| 167 | University of Lausanne | Switzerland | 26.7 | 29 | 11 | Google, Merck KGaA, Nanostring Technologies |
| 168 | École Polytechnique Fédérale de Lausanne | Switzerland | 26.5 | 30 | 4 | Roche, Leman Biotech Co., Debiopharm |
| 169 | Wake Forest University | United States | 26.4 | 24 | 6 | Samsung, AbbVie, Alvotech |
| 170 | University of South Florida | United States | 25.5 | 28 | 5 | TG Therapeutics, Gilead Sciences, Novartis |
| 171 | University of Colorado Anschutz Medical Campus | United States | 25.1 | 32 | 6 | Novartis, Bristol-Myers Squibb, Kyverna Therapeutics |
| 172 | Brown University | United States | 25.1 | 28 | 4 | Roche, Revvity, BASF |
| 173 | Okayama University | Japan | 24.5 | 30 | 2 | Oncolys BioPharma, Novartis, Takasago |
| 174 | University of Wisconsin-Madison | United States | 24.0 | 30 | 4 | Promega, Mersana Therapeutics, Johnson & Johnson |
| 175 | Maastricht University | Netherlands | 23.9 | 22 | 6 | AbbVie, Genmab, Ethris |
| 176 | China Pharmaceutical University | China | 23.7 | 22 | 4 | Jiangsu Renocell Biotech, Humanwell Healthcare Group, Nanjing Sanhome Pharmaceutical Co. |
| 177 | University of Liverpool | United Kingdom | 23.5 | 26 | 5 | TAmiRNA, MorphoSys, IDEXX Laboratories |
| 178 | Université de Montpellier | France | 22.9 | 22 | 3 | Sanofi, Bristol-Myers Squibb, EVERSANA |
| 179 | Central South University | China | 22.9 | 29 | 4 | Wuhan YZY Biopharma, Nanjing IASO Biotechnology Co., Sinocelltech Group |
| 180 | University of Lisbon | Portugal | 22.7 | 20 | 4 | AstraZeneca, Thermo Fisher Scientific, Lundbeck |
| 181 | University of Geneva | Switzerland | 21.6 | 28 | 3 | Roche, Novartis, Genovis |
| 182 | University of Würzburg | Germany | 21.4 | 25 | 5 | MorphoSys, Novartis, Munich Leukemia Laboratory |
| 183 | Hanyang University | South Korea | 21.1 | 22 | 5 | Samsung, ExoStemTech, Kyowa Kirin |
| 184 | Wuhan University | China | 20.8 | 26 | 4 | BGI Group, Celestialab, Brain Case Biotechnology |
| 185 | University of Science and Technology of China | China | 20.8 | 24 | 3 | BGI Group, Leman Biotech Co., VCANBIO Cell and Gene Engineering Corp |
| 186 | Technische Universität Dresden | Germany | 20.3 | 28 | 5 | Iovance Biotherapeutics, Boehringer Ingelheim, KLS Martin |
| 187 | Humboldt-Universität zu Berlin | Germany | 19.9 | 29 | 2 | Amgen, Miltenyi Biotec, cPHARMA |
| 188 | Anhui Medical University | China | 19.2 | 24 | 6 | Qilu Pharmaceutical Co., Wuhan YZY Biopharma, Echo Biotech |
| 189 | Case Western Reserve University | United States | 18.5 | 28 | 3 | Johnson & Johnson, Lentigen Technology, Athersys |
| 190 | Tohoku University | Japan | 17.9 | 27 | 3 | NOF Corporation, Novartis, Fushimi Pharmaceutical |
| 191 | University of Gothenburg | Sweden | 16.9 | 28 | 1 | AstraZeneca, Anjarium Biosciences, Merck |
| 192 | Université de Montréal | Canada | 16.8 | 23 | 4 | Novartis, Roche, Merck KGaA |
| 193 | Université de Strasbourg | France | 16.1 | 22 | 4 | Sanofi, Roche, Genovis |
| 194 | University of Arizona | United States | 15.7 | 20 | 2 | MATRIX45, Viatris, Otsuka |
| 195 | University of Leeds | United Kingdom | 14.9 | 22 | 5 | AstraZeneca, SyngentaSTATE-OWNED, Replimune Group |
| 196 | Weizmann Institute of Science | Israel | 14.6 | 24 | 4 | Roche, BGI Group, AstraZeneca |
| 197 | University of Padua | Italy | 14.2 | 22 | 4 | Cogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS, Boehringer Ingelheim, Targovax |
| 198 | Universidad Autónoma de Madrid | Spain | 14.2 | 21 | 3 | Biogen, Roche, Chongqing Precision Biotech Co. |
| 199 | Universidade de São Paulo | Brazil | 13.9 | 28 | 2 | Gamida Cell, Fleury S.A., AstraZeneca |
| 200 | University of Pavia | Italy | 13.8 | 22 | 4 | Philochem, AbbVie, Philogen |
| 201 | University of Illinois Chicago | United States | 13.2 | 23 | 4 | MorphoSys, BioLife Solutions, BioAtla |
| 202 | Harbin Medical University | China | 12.5 | 21 | 5 | Qilu Pharmaceutical Co., Wuhan YZY Biopharma, Suzhou Zelgen Biopharmaceuticals Co. |
| 203 | University of Hong Kong | Hong Kong | 12.4 | 22 | 3 | AstraZeneca, Johnson & Johnson, Samsung |
| 204 | Chinese University of Hong Kong | Hong Kong | 12.2 | 24 | 3 | BGI Group, AstraZeneca, Tencent |
| 205 | Leipzig University | Germany | 11.8 | 22 | 4 | Miltenyi Biotec, Boehringer Ingelheim, Servier |
| 206 | Queen Mary University of London | United Kingdom | 11.3 | 24 | 4 | Kuros Biosciences, Merck KGaA, Roche |
| 207 | Shandong First Medical University | China | 11.1 | 24 | 4 | Wuhan YZY Biopharma, Evox Therapeutics, Sinocelltech Group |
| 208 | Chalmers University of Technology | Sweden | 10.6 | 22 | 2 | AstraZeneca, DSM, Evox Therapeutics |
| 209 | University of Ottawa | Canada | 10.4 | 20 | 3 | AstraZeneca, Merck & Co. (MSD), Eli Lilly |
| 210 | Delft University of Technology | Netherlands | 9.9 | 20 | 2 | DSM, Finceramica, Pferdeklinik Leichlingen |
| 211 | Jichi Medical University | Japan | 9.8 | 20 | 4 | Kyowa Kirin, Nippon Kayaku, Takara BIO Inc. |
| 212 | Shenzhen University | China | 9.7 | 22 | 2 | BGI Group, Fundamenta Therapeutics |
| 213 | Pennsylvania State University | United States | 9.4 | 20 | 2 | Moderna Therapeutics, Genos, BioPolicy Solutions |
| 214 | Chongqing Medical University | China | 9.3 | 21 | 4 | Beijing Biosis Healing Biological Technology, BGI Group, Kuros Biosciences |
| 215 | Albert Einstein College of Medicine | United States | 9.2 | 22 | 2 | Menarini Group, Gilead Sciences, Pfizer |
| 216 | Newcastle University | United Kingdom | 8.9 | 24 | 2 | RTX, Nordic Bioscience, CellFiber |
| 217 | Southern University of Science and Technology | China | 8.7 | 21 | 2 | BGI Group, Bellagen Biotechnology, RootPath |
| 218 | University of Cincinnati | United States | 8.6 | 22 | 4 | Roche, BioLegend, AskBio |
| 219 | Shanxi Medical University | China | 7.9 | 22 | 3 | BGI Group, Wuhan YZY Biopharma, Tencent |
| 220 | Freie Universität Berlin | Germany | 7.8 | 22 | 1 | Miltenyi Biotec, cPHARMA, CP+ Associates |
Leading partners: up to three company groups with the most joint works in the sector. State-owned enterprises are marked; a partner whose name is withheld is not listed.
Funded partnerships (reported, not scored). 298 UK and EU projects starting 2021 to 2025 (143 UKRI, 155 Horizon) involve a cohort university and a company group whose main sector, by its verified joint works, is this one (281 universities): most often Miltenyi Biotec, Croda, Oxford Nanopore Technologies, Dompé Farmaceutici, Information Technology for Translational Medicine (ITTM. Sources: UKRI Gateway to Research harvested 4 Oct 2026; CORDIS bulk files of 2026-10-12 (latest record update 2026-06-10). Funded partnerships cover UK (UKRI Gateway to Research) and EU (Horizon 2020 and Horizon Europe, CORDIS) projects starting 2021 to 2025 only. They are reported, never scored, and a funder record outside these two sources is not visible here.
Bacterial Genetics and Biotechnology; Biosimilars and Bioanalytical Methods; Biotechnology and Related Fields; Bone Tissue Engineering Materials; CAR-T cell therapy research; CRISPR and Genetic Engineering; Extracellular vesicles in disease; Hematopoietic Stem Cell Transplantation; Mesenchymal stem cell research; Microbial Metabolic Engineering and Bioproduction; Monoclonal and Polyclonal Antibodies Research; Pluripotent Stem Cells Research; RNA Interference and Gene Delivery; Single-cell and spatial transcriptomics; Tissue Engineering and Regenerative Medicine; Virus-based gene therapy research
Open data
The full Biotechnology and Advanced Therapies ranking (rank, university, country, score, sector works, partners and leading partners) as an Excel workbook. Every other index is in the all-indices workbook.
Released under CC BY 4.0: reuse freely with attribution to the Industry Collaboration Index, Global Research Partnerships. How it is measured.